comprehensive -WSS

comprehensive

author：explore 2025-10-02 18:48:42 - browse：34847

What’s a radiopharmaceutical? What does it mean to be Zepbound? And who’s to blame for a biotech blow-up?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. As so-called radiopharmaceuticals make headlines in oncology, we explore their fascinating scientific backstory and the biotech gold rush to make them. We also discuss the approval of Eli Lilly’s curiously named treatment for obesity, the latest implosion for a promising biotech company, and some news in the world of shareholder activism.

For more on what we cover, here’s the radiopharmaceuticals story; here’s the news on Lilly; here’s more on Ventyx Biosciences; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Drug repurposing or repositioning? The language matters
Next article： Congress: Prevent baby formula shortages by passing a new bill

Wikipedia

WSS

J&J reports mixed data on next

Stroke rates rising, especially in working

Curing rare childhood diseases will falter unless Congress steps up

Report captures long Covid’s disabling effects and policy challenges

Louisiana bill approved classifying abortion pills as controlled substances

The Bio Revolution is changing business and society

leisure time

comprehensive

leisure time

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The world needs the new pandemic treaty

Guidelines to prevent youth baseball injuries need more muscle

Cheap, fast test for Zika and dengue could cost just $1

Cancer drug shortages should be causing more outrage

ALS patient reclaims some autonomy thanks to wearable 'robot'

After affirmative action ruling, medical educators look to 'holistic review'

The system is set up to fail children with medical complexity

United colonoscopy coverage change 'may cost lives,' doctors say

Teladoc has a new CEO, but challenges remain the same

hotspot

Teladoc has a new CEO, but challenges remain the same

U.S. death rates show how politics are affecting public health

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Coercive sterilizations revealed by STAT prompt outrage

Cigna wins case to block Amy Bricker's move to CVS

Pharma companies must ensure equitable access to obesity drugs

entertainment

Wikipedia

leisure time

hotspot